ImmunityBio, Inc. business relationships

Companies named in ImmunityBio, Inc.’s 10-K filed 2026-02-23, and public companies whose annual reports name ImmunityBio, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.5 / 10
AI naming: 72 / 100
Agent readiness: 35 / 100
AI adoption: 0 / 100

Named in ImmunityBio, Inc.’s annual report 4

3M CO (MMM)Licensee7.7
“We have licensed rights to 3M-052, a synthetic TLR7/8 agonist, 3M-052 formulations and related technology from 3M IPC and its affiliates and AAHI.” SEC filing
3M CO (MMM)Licensor7.7
“3M IPC and AAHI License Agreement” SEC filing
Merck & Co., Inc. (MRK)Supplier7.7
“This addresses a significant supply challenge: TICE BCG (Merck) has been the sole supplier of BCG product in the U.S. since 2012, and rationing has been ongoing since 2019.” SEC filing
NantWorks, LLCLicensor5.4
“Facility License Agreement by and between NantWorks, LLC and the Company, dated as of November 6, 2015.” SEC filing

Companies whose annual reports name ImmunityBio, Inc. 2

HCW Biologics Inc. (HCWB)names it as licensor4.7
“The Company agreed to provide ImmunityBio with a right of first refusal to enter a licensing agreement for oncology indications for HCW9206.” SEC filing
HCW Biologics Inc. (HCWB)names it as supplier4.7
“Under the terms of the Settlement Agreement, ImmunityBio will own the cell line and supply for HCW9218, and the parties agreed that within six months from the date of the Settlement Agreement they will enter into a supply agreement providing the Company with a continuing supply of HCW9218 molecules.” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.